Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 3
1955 2
1956 2
1957 4
1958 1
1961 3
1962 2
1963 3
1966 5
1967 3
1968 5
1969 4
1970 7
1971 5
1972 9
1973 5
1974 4
1975 5
1976 13
1977 10
1978 13
1979 6
1980 9
1981 10
1982 14
1983 18
1984 24
1985 18
1986 30
1987 42
1988 43
1989 56
1990 56
1991 53
1992 62
1993 94
1994 83
1995 95
1996 101
1997 83
1998 98
1999 83
2000 99
2001 74
2002 112
2003 118
2004 93
2005 108
2006 103
2007 112
2008 113
2009 133
2010 127
2011 135
2012 155
2013 157
2014 147
2015 144
2016 151
2017 148
2018 151
2019 140
2020 119
Text availability
Article attribute
Article type
Publication date

Search Results

3,498 results
Results by year
Filters applied: . Clear all
Page 1
Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.
Dalle JH, Giralt SA. Dalle JH, et al. Biol Blood Marrow Transplant. 2016 Mar;22(3):400-9. doi: 10.1016/j.bbmt.2015.09.024. Epub 2015 Oct 23. Biol Blood Marrow Transplant. 2016. PMID: 26431626 Free article. Review.
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), can develop in a subset of patients, primarily after myeloablative hematopoietic stem cell transplantation, but it also may occur after reduced-intensity conditioning. …
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome (SOS), can develop in a subset of p …
Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome.
Corbacioglu S, Jabbour EJ, Mohty M. Corbacioglu S, et al. Biol Blood Marrow Transplant. 2019 Jul;25(7):1271-1280. doi: 10.1016/j.bbmt.2019.02.018. Epub 2019 Feb 22. Biol Blood Marrow Transplant. 2019. PMID: 30797942 Free article. Review.
Veno-occlusive disease, also known as sinusoidal obstruction syndrome (VOD/SOS), is a potentially life-threatening complication of allogeneic or autologous hematopoietic stem cell transplantation (HSCT) most commonly associated with high-intensity chemotherap
Veno-occlusive disease, also known as sinusoidal obstruction syndrome (VOD/SOS), is a potentially life-threatening comp
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, Boelens JJ, Hewitt A, Schrum J, Schulz AS, Müller I, Stein J, Wynn R, Greil J, Sykora KW, Matthes-Martin S, Führer M, O'Meara A, Toporski J, Sedlacek P, Schlegel PG, Ehlert K, Fasth A, Winiarski J, Arvidson J, Mauz-Körholz C, Ozsahin H, Schrauder A, Bader P, Massaro J, D'Agostino R, Hoyle M, Iacobelli M, Debatin KM, Peters C, Dini G. Corbacioglu S, et al. Lancet. 2012 Apr 7;379(9823):1301-9. doi: 10.1016/S0140-6736(11)61938-7. Epub 2012 Feb 23. Lancet. 2012. PMID: 22364685 Clinical Trial.
BACKGROUND: Hepatic veno-occlusive disease is a leading cause of morbidity and mortality after haemopoietic stem-cell transplantation (HSCT). ...Patients in either group who developed veno-occlusive disease received defibrotide for treatm …
BACKGROUND: Hepatic veno-occlusive disease is a leading cause of morbidity and mortality after haemopoietic stem-cell t …
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. Dignan FL, et al. Br J Haematol. 2013 Nov;163(4):444-57. doi: 10.1111/bjh.12558. Epub 2013 Sep 17. Br J Haematol. 2013. PMID: 24102514
N-acetylcysteine is not routinely recommended for use in the treatment of veno-occlusive disease due to lack of efficacy (1A). Methylprednisolone may be considered for use in the treatment of veno-occlusive disease with the appropriate ca …
N-acetylcysteine is not routinely recommended for use in the treatment of veno-occlusive disease due to lack of efficac …
Treatment of hepatic veno-occlusive disease in children with N-acetylcysteine.
Lee AC, Aung L. Lee AC, et al. Pediatr Blood Cancer. 2019 Feb;66(2):e27518. doi: 10.1002/pbc.27518. Epub 2018 Oct 23. Pediatr Blood Cancer. 2019. PMID: 30350914
In our institution, hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) has been treated with N-acetylcysteine (NAC) since 2008-a loading dose of 150 mg/kg, followed by 12 doses of 70 mg/kg 6 hourly. ...
In our institution, hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) has been treated with N-ac …
Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ortiz-Bautista C, Hernández-González I, Escribano-Subías P. Ortiz-Bautista C, et al. Med Clin (Barc). 2017 Mar 22;148(6):265-270. doi: 10.1016/j.medcli.2016.11.031. Epub 2017 Jan 22. Med Clin (Barc). 2017. PMID: 28118962 Review. English, Spanish.
Despite the advances in genetic, cellular and molecular basis knowledge in the last decade, pulmonary veno-occlusive disease remains as a rare aetiology of pulmonary hypertension without any effective medical treatment approved and poor outcomes. This documen …
Despite the advances in genetic, cellular and molecular basis knowledge in the last decade, pulmonary veno-occlusive diseas
Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience.
Patrono D, Marola S, David E, Chiusa L, Martini S, Mirabella S, Lupo F, Salizzoni M, Romagnoli R. Patrono D, et al. Exp Clin Transplant. 2019 Apr;17(2):214-221. doi: 10.6002/ect.2017.0315. Epub 2018 Oct 24. Exp Clin Transplant. 2019. PMID: 30381049 Free article.
The incidence of veno-occlusive disease was 0.3% (7/2165). RESULTS: Timing of veno-occlusive disease onset (median 4.7 mo; interquartile range, 2.5-11.1 mo) varied widely as did clinical presentation, which was characterized by a variable …
The incidence of veno-occlusive disease was 0.3% (7/2165). RESULTS: Timing of veno-occlusive disease
Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.
Günther S, Perros F, Rautou PE, Girerd B, Ghigna MR, Cazals-Hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D. Günther S, et al. Am J Pathol. 2019 Jun;189(6):1159-1175. doi: 10.1016/j.ajpath.2019.02.007. Epub 2019 Mar 26. Am J Pathol. 2019. PMID: 30926335 Free article. Review.
Hepatic veno-occlusive disease (HVOD), alias sinusoidal obstruction syndrome, may develop as a complication of chemotherapy in the setting of hematopoietic stem cell transplantation. ...Veno-occlusive disease may also affect the lungs, an …
Hepatic veno-occlusive disease (HVOD), alias sinusoidal obstruction syndrome, may develop as a complication of chemothe …
Pulmonary veno-occlusive disease.
[No authors listed] [No authors listed] Radiographics. 2007 May-Jun;27(3):866. doi: 10.1148/radiographics.27.3.0270866. Radiographics. 2007. PMID: 17503550 Review. No abstract available.
Pulmonary veno-occlusive disease.
Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, Sitbon O, Musset D, Simonneau G, Humbert M. Montani D, et al. Eur Respir J. 2009 Jan;33(1):189-200. doi: 10.1183/09031936.00090608. Eur Respir J. 2009. PMID: 19118230 Free article. Review.
Pulmonary veno-occlusive disease (PVOD) is currently classified as a subgroup of pulmonary arterial hypertension (PAH) and accounts for 5-10% of cases initially considered to be idiopathic PAH. ...
Pulmonary veno-occlusive disease (PVOD) is currently classified as a subgroup of pulmonary arterial hypertension (PAH) …
3,498 results
Jump to page
Feedback